Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
《糖尿病技术与治疗学》是唯一一本同行评审期刊，为医疗保健专业人士提供有关糖尿病患者管理的新设备、药物、给药系统和软件的信息。这本领先的国际期刊提供实用信息和该领域前沿技术和治疗的全面报道，每期都重点介绍新的药理学和器械开发，以优化患者护理。
Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2018.0264
Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2018.0374
Adoption of New Glucose-Lowering Medications in the U.S. - the case of SGLT2 inhibitors: Nationwide cohort study.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0213
Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide-1 Receptor Agonist.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0185
Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0278
Reviewing Connected Diabetes Care: The Newest Member of the Team.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0273
A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.0020
An Intervention to Reduce Hypoglycemia Fear in Parents of Young Kids with Type 1 Diabetes via Video-Based Telemedicine (REDCHIP): Trial Design, Feasibility, and Acceptability.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0244
Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2018.0298
Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0026
Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0007
Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.0303
Documentation of skin-related issues associated with CGM use in the scientific literature.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0171
High prevalence of skin reactions among pediatric patients with type 1 diabetes using new technologies: the alarming role of colophonium.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0236
Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.0148
Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0387
Differences for Percentage Times in Glycaemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0276
Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.0157
Telemedicine-Assisted Self-Management Program for Type 2 Diabetes Patients.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0056
Use of Telemedicine Technologies in Diabetes Prevention and Control in Resource-Constrained Settings: Lessons Learned from Emerging Economies
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/DIA.2019.0038
Changes in Accuracy of Continuous Glucose Monitoring Using Dexcom G4 Platinum Over the Course of Moderate Intensity Aerobic Exercise in Type 1 Diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0400
Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0295
GREATER SUPPRESSION OF GLUCAGON, LIPOLYSIS AND KETOGENESIS WITH INSULIN GLARGINE U300 AS COMPARED TO GLARGINE U100 IN TYPE 1 DIABETES MELLITUS.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0231
Effectiveness and safety of physician versus patient-led titration of insulin glargine in Indian patients with type 2 diabetes mellitus: A sub-analysis of the Asian Treat to Target Lantus Study (ATLAS).
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0037
Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0393
EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETES
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.2525.abstracts
Switching from suspend-before-low insulin pump technology to a hybrid closed loop system improves glucose control and reduces glucose variability: a retrospective observational case-control study.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0302
Accuracy of FreeStyle Libre in adults with type 1 diabetes: the effect of sensor age.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0262
Improvement in psychosocial outcomes in children with type 1 diabetes and their parents following subsidy for continuous glucose monitoring.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0149
A Digital-First Model of Diabetes Care.
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/DIA.2019.0058
The Choice should be Yours: Diabetes-related Distress by Insulin Delivery Method for Patients with Type 1 Diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0228
Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.0446
Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-Label Use Protocol for Clinical Practice.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0316
Efficacy and Safety of Tofogliflozin on 24-H Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0099
Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0046
Effect of a Novel High Fiber Rice Diet on 24-Hour Glycemic Responses in Asian Indians Using Continuous Glucose Monitoring: A Randomized Clinical Trial.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0350
Predicting Nocturnal Hypoglycemia with Measures of Physical Activity Intensity in Adolescent Athletes with Type 1 Diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0048
Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0205
Demystifying the pizza bolus- the effect of dough fermentation on glycemic response - a sensor augmented pump intervention trial in children with type 1 diabetes mellitus.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0191
Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0346
Insulin pump settings during breastfeeding in women with type 1 diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0280
No Effect of an Automated Bolus Calculator in Pediatric Patients with Type 1 Diabetes on Multiple Daily Injections: The Expert Kids Study.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0064
Prospective analysis of the impact of commercialised hybrid closed-loop system on glycaemic control, glycaemic variability and patient-related outcomes in children and adults: a focus on superiority over predictive low glucose suspend technology.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0400
Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes
来源期刊：Diabetes Technology & TherapeuticsDOI：10.1089/dia.2019.0356
Self-monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0369
The beneficial effect of the mobile application Euglyca® in Children and Adolescents with Diabetes Mellitus Type 1. A randomized controlled trial.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0170
Development and psychometric validation of the novel Glucose Monitoring Experiences Questionnaire (GME-Q) among adults with type 1 diabetes.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0189
Cost of Treating Skin Problems in Patients with Diabetes who Use Insulin Pumps and/or Glucose Sensors.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0368
Feasibility of blood glucose management using intra-arterial glucose monitoring in combination with an automated insulin titration algorithm in critically ill patients.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2019.0082
Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy.
来源期刊：Diabetes technology & therapeuticsDOI：10.1089/dia.2018.0356
